Bio Ascend, a Vaniam Group Company, Reconvenes Inaugural Class of the "Academy of Next Wave of Investigators™" in CLL and NHL
SAN DIEGO, Dec. 11, 2023 /PRNewswire/ -- Bio Ascend, Vaniam Group's medical education company, this past weekend reconvened the inaugural class of its Academy of Next Wave of Investigators™ at a networking reception during the 65th annual American Society of Hematology (ASH) annual meeting. These young clinical investigators are participating in a year-long opportunity to engage in live and virtual career development seminars with international thought leaders in the fields of chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL).
- These young clinical investigators are participating in a year-long opportunity to engage in live and virtual career development seminars with international thought leaders in the fields of chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL).
- "This next generation of hematology leaders is at a critical moment in their promising careers," said Kraig Steubing, Head of Bio Ascend and Senior Vice President of Strategic Engagement at Vaniam Group.
- We wholeheartedly thank the members of our inaugural class, our distinguished faculty, and the program's sponsors."
- In the subsequent months, the early-career investigators have been meeting regularly with their assigned mentors, prior to reconvening in person at the ASH annual meeting this past weekend.